Experience

Autism Diagnostic Technologies

• United States
• Medical Practices
• 1 - 100 Employee

• CEO

  • Mar 2017 - 6 years 10 months

  Basking Ridge, NJ 07920 Autism Diagnostic Technologies, Inc. has developed a method of mapping brains using current technologies combined with a unique invention to compare normal brains to autistic, dyslexic, and Alzheimer’s affected brains. The new technology can be integrated with existing MRI scan equipment to provide: Faster and more accurate analysis of the brain using three dimensional mesh mapping to determine significant locations that correlate with brain structure and disease Can diagnose… Show more Autism Diagnostic Technologies, Inc. has developed a method of mapping brains using current technologies combined with a unique invention to compare normal brains to autistic, dyslexic, and Alzheimer’s affected brains. The new technology can be integrated with existing MRI scan equipment to provide: Faster and more accurate analysis of the brain using three dimensional mesh mapping to determine significant locations that correlate with brain structure and disease Can diagnose Autism in infants as young as six months old at 90% rate of accuracy Measures the thickness of Cerebral White Matter (CWM) gyrification; and analyzes the shape of and classifies brain based on this measurement Considered a smart technology, it can “learn” as more data is added, which will increase accuracy of diagnoses Show less



Medeject, Inc

• United States
• Business Consulting and Services
• 1 - 100 Employee

• CEO

  • Nov 2016 - Jun 2018

  Basking Ridge, NJ Food allergies continue to be a significant public health concern as there are as many as 15 million people worldwide that have food allergies with nearly 6 million being children (or 8% of all children). The problem with existing epinephrine auto-injectors on the market can best be summarized by the following; 1) There is no auto-injector currently on the market that delivers the appropriate dose of epinephrine and has the appropriate needle size for infants and young children; 2) The… Show more Food allergies continue to be a significant public health concern as there are as many as 15 million people worldwide that have food allergies with nearly 6 million being children (or 8% of all children). The problem with existing epinephrine auto-injectors on the market can best be summarized by the following; 1) There is no auto-injector currently on the market that delivers the appropriate dose of epinephrine and has the appropriate needle size for infants and young children; 2) The administration technique of current auto-injector devices may be intimidating to non-healthcare professionals and some design features may increase the risk of improper administration technique in emergency scenarios, resulting in inadequate medication delivery and; 3) The cost of the EPIPEN device has increased 400% ($58 to $600) over the last number of years and has become unaffordable to the masses. Show less



Wipe-Rite Technologies, Inc.

• CEO

  • Feb 2016 - May 2017

  Greater New York City Area Wipe-Rite Technology, a medical marketplace start up technology to be used for decontaminating IV catheters used in ICU, Medical Floors and Hemodialysis Centers. Central Line infections of 80,000 patients per year add $1 billion cost uncompensated to hospitals and clinics per year in the USA. Up to 14,000 patients per year die. Our goal is to help to eliminate these unnecessary infections by helping nurses and doctors with the challenge of cleaning the contamination.



Whetstone Associates LLC

• Medical Equipment Manufacturing

• Partner

  • Mar 2013 - Feb 2016

  New jersey Marketing consultant with focus on strategic product or service line identification and development as part of Park Technology working with Corey Park and Jason Pottinger. Previously engaged with 35 member medical specialty group focused on development of strategic positioning.



NewCo

• Greece
• IT Services and IT Consulting
• 1 - 100 Employee

• President/CEO

  • May 2013 - Jun 2014

  New Jersey I created a team to develop a market development strategy for an innovative orthopedic solution in the trauma market. We further offered a Letter of Intent to obtain the technology for purposes of commercialization and forming a new company LLC.



EyeTect, LLC

• President/CEO

  • Jun 2005 - Mar 2013

  New Jersey Successfully completed the next round of funding including the founder's exit. Developed start up medical device firm focused on the critical care segment. Unique Ocular Micro Tremor technology under development helps clinicians manage patient's depth of consciousness.



Ethicon

• Belgium

• Vice President Sales, Board of Directors

  • Jul 1994 - Mar 2003

  Senior sales executive and member of management board for the $1B medical device division of J&J. Additional responsibilities included strategic planning, reengineering implementation, contract/price management, marketing planning team leadership reporting to company President.



Johnson & Johnson Professional

• Vice President Sales and Marketing, Board of Directors

  • May 1993 - Jun 1994

  Raynham, Ma Served as Vice President of Sales and Marketing Worldwide for Neurosurgical Division. Reported to the President and served on its management board.



Codman and Shurtleff, Inc.

• Vice President Sales and Marketing, Board of Directors

  • Mar 1989 - May 1993

  Senior sales and marketing executive and member of management board for $150 million division of J&J. Additional responsibilities included strategic planning, business development, new product planning, reengineering implementation, contract/price management, reporting to company President.